COL15A1 and sarcoma: None of the tested cancer cell lines, namely T241 sarcoma, LLC1 Lewis lung carcinoma or B16F10 melanoma, showed differences in primary tumour growth rates between Col15a1+/+ and Col15a1−/− mice when injected subcutaneously (Figure 4D–F).